WO2017108569A1 - Pesticidally active pyrazole derivatives - Google Patents

Pesticidally active pyrazole derivatives Download PDF

Info

Publication number
WO2017108569A1
WO2017108569A1 PCT/EP2016/081167 EP2016081167W WO2017108569A1 WO 2017108569 A1 WO2017108569 A1 WO 2017108569A1 EP 2016081167 W EP2016081167 W EP 2016081167W WO 2017108569 A1 WO2017108569 A1 WO 2017108569A1
Authority
WO
WIPO (PCT)
Prior art keywords
pyrazol
methyl
chloro
trifluoromethyl
benzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2016/081167
Other languages
English (en)
French (fr)
Inventor
André Jeanguenat
Myriem El Qacemi
Thomas Pitterna
André Stoller
Régis Jean Georges MONDIERE
Aurelien BIGOT
Andrew Edmunds
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Participations AG
Original Assignee
Syngenta Participations AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Participations AG filed Critical Syngenta Participations AG
Priority to CN201680075075.3A priority Critical patent/CN108463109B/zh
Priority to JP2018532553A priority patent/JP6943857B2/ja
Priority to BR112018012926-7A priority patent/BR112018012926B1/pt
Priority to EP16809111.4A priority patent/EP3393245A1/en
Priority to MX2018007527A priority patent/MX2018007527A/es
Priority to US16/064,916 priority patent/US10750742B2/en
Priority to CA3006911A priority patent/CA3006911C/en
Publication of WO2017108569A1 publication Critical patent/WO2017108569A1/en
Priority to CONC2018/0006320A priority patent/CO2018006320A2/es
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/713—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with four or more nitrogen atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N53/00—Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Definitions

  • the present invention relates to pyrazole derivatives, to processes for preparing them, to intermediates for preparing them, to pesticidal, in particular insecticidal, acaricidal, molluscicidal and nematicidal compositions comprising those derivatives and to methods of using them to combat and control pests such as insect, acarine, mollusc and nematode pests.
  • the present invention relates to a compound of formula (I),
  • R is selected from H, Ci-Ce-alkyl, C2-C6 alkenyl, C2-C6 alkinyl, C3-C7 cycloalkyi, C3-C7 cycloalkyi- C1 C3- alkyl, Ci C6-alkylcarbonyl, Ci C6-alkoxycarbonyl, aryl(Co-C3)-alkyl and heteroaryl(Co-C3)-alkyl, wherein each of Ci-Ce-alkyl, C2-C6 alkenyl, C2-C6 alkinyl, C3-C7 cycloalkyi, C3-C7 cycloalkyi- Ci C3-alkyl, C1 C6- alkylcarbonyl, Ci C6-alkoxycarbonyl, aryl(Co-C3)-alkyl and heteroaryl(Co-C3)-alkyl is unsubstituted or substituted with 1 to 10 substituents independently selected from halogen, cyano, Ci
  • W is O or S
  • a 1 is CR 2 or N;
  • a 2 is CR 3 or N;
  • a 3 is CR 4 or N
  • a 4 is CR 5 or N
  • R 2 , R 3 , R 4 and R 5 are independently selected from H, halogen, cyano, nitro, Ci-Ce-alkyl, Ci C6-alkoxy, N- Ci-C6-alkoxy-imino-Ci C3-alkyl, Ci C6-alkylsulfanyl, Ci-Ce-a I ky I s u If i n y I , Ci C6-alkylsulfonyl, N- Ci-Ce- alkylamino and ⁇ /,/V-di- Ci C6-alkylamino, wherein each of Ci-Ce-alkyl, Ci C6-alkoxy, N- Ci C6-alkoxy- imino-Ci-C3-alkyl, Ci C6-alkylsulfanyl, Ci C6-alkylsulfinyl, Ci C6-alkylsulfonyl, N- Ci C6-alkylamino and
  • T is a 5-membered heteroaryl of formula
  • D is selected from CR 6a , N, NR 6b , O and S;
  • D 2 is selected from CR 7a , N, NR 7b , O and S;
  • D 3 is C or N
  • D 4 is selected from CR 8a , N, NR 8b , S and O;
  • D 5 is C or N
  • D , D 2 , D 3 , D 4 and D 5 is selected from N, O and S, and that no more than one of D , D 2 and D 4 is O or S, and that at least one of D 3 and D 5 is C;
  • R 6a , R 7a and R 8a are independently selected from H, halogen, cyano, nitro, amino, Ci-Ce-alkyl, C1 C6- alkoxy, Ci C6-alkylcarbonyl, Ci C6-alkylsulfanyl, Ci C6-al ky Is u If i ny I and Ci C6-alkylsulfonyl, wherein each of Ci C6-alkyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci C6-alkylsulfanyl, Ci C6-alkylsulfinyl, C1 C6- alkylsulfonyl is unsubstituted or substituted with 1 to 5 halogen;
  • R 6b , R 7b and R 8b are independently selected from H and Ci-Ce-alkyl, wherein each of Ci-Ce-alkyl is unsubstituted or substituted with 1 to 5 halogen;
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, CiCe-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 13 substituents independently selected from halogen;
  • Z is selected from Ci-Cio-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkoxy-Ci-C 6-alkyl, C2- Cio-alkenyl, C2-C 10-alkynyl, -(Co-C 6-alkyl)-C3-C7 heterocycloal
  • Z 2 is selected from H, halogen, cyano, nitro, amino, Ci-Ce-alkyl, Ci C6-alkylcarbonyl, Ci C6-alkylsulfanyl, Ci C6-al ky Is u If i ny I and Ci C6-alkylsulfonyl, wherein each of Ci-Ce-alkyl, Ci C6-alkylcarbonyl, C1 C6- alkylsulfanyl, Ci C6-alkylsulfinyl and Ci C6-alkylsulfonyl is unsubstituted or substituted with 1 to 5 substituents independently selected from halogen, hydroxy, nitro, amino, cyano, Ci C6-alkoxy, C1 C6- alkoxycarbonyl, hydroxycarbonyl, Ci C6-alkylcarbamoyl, C3-C6-cycloalkylcarbamoyl and phenyl;
  • Z 3 is selected from H, Ci-Ce-alkyl, Ci C6-cycloalkyl, Ci C6-alkenyl, Ci-Ce-alkinyl, aryl and heteroaryl, wherein each of Ci-Ce-alkyl, Ci-Ce-cycloalkyl, Ci-Ce-alkenyl, Ci-Ce-alkinyl, aryl and heteroaryl is unsubstituted or substituted with 1 to 5 substituents independently selected from halogen, hydroxy, nitro, amino, cyano, Ci C6-alkoxy, Ci C6-alkoxycarbonyl, hydroxycarbonyl, Ci C6-alkylcarbamoyl, C3-C6- cycloalkylcarbamoyl and phenyl;
  • a 1 , A 2 , A 3 , A 4 , D ⁇ D 2 , D 3 , D 4 , D 5 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6a , R 6b , R 7a , R 7b , R 8a , R 8b , Q, U, Z , Z 2 and Z 3 in relation to each compound of the present invention, including the intermediate compounds, are as set out below in embodiments 2 to 78.
  • Embodiment 2 A compound or salt according to embodiment 1 of formula (I)
  • R is selected from H, Ci-Ce-alkyl, C3-C6 alkenyl, C3-C6 alkinyl, C3-C7 cycloalkyi, C3-C7 cycloalkyi- C1-C3- alkyl, Ci C6-alkylcarbonyl, Ci C6-alkoxycarbonyl, aryl(Co-C3)-alkyl and heteroaryl(Co-C3)-alkyl, wherein each of Ci-Ce-alkyl, C3-C6 alkenyl, C3-C6 alkinyl, C3-C7 cycloalkyi, C3-C7 cycloalkyi- Ci C3-alkyl, Ci-Ce- alkylcarbonyl, Ci C6-alkoxycarbonyl, aryl(Co-C3)-alkyl and heteroaryl(Co-C3)-alkyl is unsubstituted or substituted with 1 to 5 substituents independently selected from halogen,
  • W is O or S
  • a 1 is CR 2 or N
  • a 2 is CR 3 or N
  • a 3 is CR 4 or N
  • a 4 is CR 5 or N
  • R 2 , R 3 , R 4 and R 5 are independently selected from H, halogen, cyano, nitro, Ci-Ce-alkyl, Ci C6-alkoxy, N- Ci-C6-alkoxy-imino-Ci C3-alkyl, Ci C6-alkylsulfanyl, C 1-Ce-a I ky I s u If i n y I , Ci C6-alkylsulfonyl, N- Ci-Ce- alkylamino and ⁇ /,/V-di- Ci C6-alkylamino, wherein each of Ci-Ce-alkyl, Ci C6-alkoxy, N- Ci C6-alkoxy- imino-Ci-C3-alkyl, Ci-Ce-alkylsulfanyl, Ci-Ce-al ky Is u Ifi ny I , Ci-Ce-alkylsulfonyl, N- Ci C6
  • T is a 5-membered heteroaryl of formula
  • D is selected from CR 6a , N, NR 6b , O and S;
  • D 2 is selected from CR 7a , N, NR 7b , O and S;
  • D 3 is C or N
  • D 4 is selected from CR 8a , N, NR 8b , S and O;
  • D 5 is C or N; with the proviso that at least one of D ⁇ D 2 , D 3 , D 4 and D 5 is selected from N, O and S, and that no more than one of D ⁇ D 2 and D 4 is O or S, and that at least one of D 3 and D 5 is C;
  • R 6a , R 7a and R 8a are independently selected from H, halogen, cyano, nitro, amino, Ci C6-alkyl, C1-C6- alkoxy, Ci C6-alkylcarbonyl, Ci&e-alkylsulfanyl, Ci C6-al ky Is u If i ny I and Ci C6-alkylsulfonyl, wherein each of Ci C6-alkyl, CiGe-alkoxy, Ci C6-alkylcarbonyl, Ci&e-alkylsulfanyl, Ci C6-alkylsulfinyl, C1 C6- alkylsulfonyl is unsubstituted or substituted with 1 to 5 halogen;
  • R 6b , R 7b and R 8b are independently selected from H and Ci C6-alkyl, wherein each of Ci C6-alkyl is unsubstituted or substituted with 1 to 5 halogen;
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-Ce-alkoxy, Ci-Ce-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci C6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from Ci-C 6-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkoxy-Ci-C 6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, -(Co-C 6-alkyl)-C3-C7 heterocycloalkyl, -(Co-C 6-alkyl)-C3-C6-cycloalkyl, wherein each of Ci-C 6-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkoxy-Ci-C 6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, -(Co-C 6-alkyl)-C3-C7 heterocycloalkyl, -(Co-C 6-alkyl)-C3-C6-cycloalkyl is unsubstituted or substituted with
  • Z 2 is selected from H, halogen, cyano, nitro, amino, Ci C6-alkyl, Ci C6-alkylcarbonyl, Ci C6-alkylsulfanyl, Ci C6-al ky Is u If i ny I and Ci C6-alkylsulfonyl, wherein each of Ci C6-alkyl, Ci C6-alkylcarbonyl, C1 C6- alkylsulfanyl, Ci C6-alkylsulfinyl and Ci C6-alkylsulfonyl is unsubstituted or substituted with 1 to 5 substituents independently selected from halogen, hydroxy, nitro, amino, cyano, Ci C6-alkoxy, C1 C6- alkoxycarbonyl, hydroxycarbonyl, Ci C6-alkylcarbamoyl, C3-C6-cycloalkylcarbamoyl and phenyl;
  • Z 3 is selected from H, Ci C6-alkyl, Ci C6-cycloalkyl, Ci C6-alkenyl, Ci C6-alkinyl, aryl and heteroaryl, wherein each of Ci C6-alkyl, Ci C6-cycloalkyl, Ci C6-alkenyl, Ci C6-alkinyl, aryl and heteroaryl is unsubstituted or substituted with 1 to 5 substituents independently selected from halogen, hydroxy, nitro, amino, cyano, Ci C6-alkoxy, Ci C6-alkoxycarbonyl, hydroxycarbonyl, Ci C6-alkylcarbamoyl, C3-C6- cycloalkylcarbamoyl and phenyl;
  • Embodiment 2.1 A compound or salt according to embodiment 1 , wherein T is selected from
  • Embodiment 3 A compound or salt according to embodiment 1 , wherein T is selected from
  • Embodiment 4 A compound or salt according to embodiment 1 , wherein T is selected from
  • Embodiment 5 A compound or salt according to embodiment 1 , wherein T is selected from
  • Embodiment 5.1 A compound or salt according to embodiment 1 , wherein T is selected from
  • Embodiment 6 A compound or salt according to embodiment 1 , wherein T is
  • Embodiment 7 A compound or salt according to any one of embodiments 1 to 6, wherein R is selected from H, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-b utyl, propenyl, methoxymethyl, ethoxymethyl, propoxymethyl, methylcarbonyl, ethylcarbonyl, n- propylcarbonyl, isopropylcarbonyl, s-butylcarbonyl, t-butylcarbonyl, methoxycarbonyl, ethoxycarbonyl, n- propoxycarbonyl, isopropoxycarbonyl, s-butoxycarbonyl, t-butoxycarbonyl, cyanomethyl, 2-cyanoethyl, benzyl, 4-methoxybenzyl, pyrid-2-yl-m ethyl, pyrid-3-yl-
  • Embodiment 8 A compound or salt according to any one of embodiments 1 to 6, wherein
  • R is selected from H, methyl, ethyl, n-propyl, n-propylcarbonyl and propenyl.
  • Embodiment 9 A compound or salt according to any one of embodiments 1 to 6, wherein
  • R is H or methyl, in particular H.
  • Embodiment 10 A compound or salt according to any one of embodiments 1 to 9, wherein
  • Embodiment 1 1 A compound or salt according to any one of embodiments 1 to 9, wherein
  • Q is selected from H, methyl, ethyl, n-propyl, 1 -cyano-cyclopropyl, (E)-1 ,2,3,3,3-pentafluoroprop-1-enyl, cyanomethyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2- trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;
  • Q is selected from phenyl, naphthyl, pyridazine, pyrazine, pyrimidine, triazine, pyridine, pyrazole, thiazole isothiazole, oxazole, isoxazole, triazole, imidazole, furan, thiophene, pyrrole, oxadiazole, thiadiazole, tetrazole and tetrahydrofuran, each of which is unsubstituted or substituted with 1 to 4 substituents independently selected from V;
  • V is selected from fluoro, chloro, bromo, iodo, cyano, nitro, methyl, ethyl, difluoromethyl, hydroxyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2- fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1 ,2,2,2-tetrafluoroethyl, 1 -chloro- 1 ,2,2,2- tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2-difluoroethyl, 1 , 1 -dilfluoroethyl, pentafluoroethyl heptafluoro-n-propyl, heptafluoro-isopropyl, nonafluoro-n-
  • Embodiment 1 1.1 A compound or salt according to any one of embodiments 1 to 9, wherein
  • Q is selected from H, methyl, ethyl, n-propyl, 1 -methylethyl, 1 , 1 -dimethylethyl, 1 -methylpropyl, n-butyl,
  • Q is selected from phenyl, naphthyl, pyridazine, pyrazine, pyrimidine, triazine, pyridine, pyrazole, thiazole isothiazole, oxazole, isoxazole, triazole, imidazole, furan, thiophene, pyrrole, oxadiazole, thiadiazole, tetrazole and tetrahydrofuran, each of which is unsubstituted or substituted with 1 to 4 substituents independently selected from V;
  • V is selected from fluoro, chloro, bromo, iodo, cyano, nitro, methyl, ethyl, difluoromethyl, hydroxyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2- fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1 ,2,2,2-tetrafluoroethyl, 1 -chloro- 1 ,2,2,2- tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2-difluoroethyl, 1 , 1 -dilfluoroethyl, pentafluoroethyl heptafluoro-n-propyl, heptafluoro-isopropyl, nonafluoro-n-
  • Embodiment 12 A compound or salt according to any one of embodiments 1 to 9, wherein
  • Q is selected from 1 -cyano-cyclopropyl, (E)-1 ,2,3,3,3-pentafluoroprop-1-enyl, cyanomethyl, benzyl, cyclopropyl, methyl, ethyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;
  • Embodiment 12.1 A compound or salt according to any one of embodiments 1 to 9, wherein
  • Q is selected from 1 -cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl.
  • Embodiment 13 A compound or salt according to any one of embodiments 1 to 12, wherein
  • Embodiment 14 A compound or salt according to any one of embodiments 1 to 13, wherein
  • a 1 is CR 2 or N
  • a 2 is CR 3 or N
  • a 3 is CR 4 or N
  • a 4 is CR 5 or N
  • R 2 and R 5 are independently selected from H, methyl, fluoro and chloro;
  • R 3 and R 4 are independently selected from H, fluoro, chloro, bromo, iodo, cyano, nitro, methyl, ethyl, fluoromethyl, difluoromethyl, chlorodifluoromethyl, trifluoromethyl, 2,2,2-trilfluoroethyl, methoxy, ethoxy, n-propoxy, 1 -methylethoxy, fluoromethoxy, difluoromethoxy, chloro-difluoromethoxy, dichloro- fluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2,2-difluorethoxy, pentafluoroethoxy, N- methoxyiminomethyl, 1-(N-methoxyimino)-ethyl, methylsulfanyl, trifluoromethylsulfanyl, methylsulfonyl, methylsulfinyl, trifluoromethylsul
  • a 1 and A 4 are CH;
  • a 2 is CH, CF or N
  • a 3 is CH or CCI.
  • Embodiment 15.1 A compound or salt according to any one of embodiments 1 to 13, wherein
  • a 1 and A 4 are CH;
  • a 2 is CH or CF
  • Embodiment 16 A compound or salt according to any one of embodiments 1 to 15, wherein
  • R 6a , R 7a and R 8a are independently selected from H, halogen, cyano, nitro, amino, methyl, ethyl, propyl, 1- methylethyl, tert-butyl, trifluoromethyl, difluoromethyl, methoxy, ethoxy, trifluoromethoxy, 2,2- difluoroethoxy, 2,2,2-trifluoroethoxy, methylcarbonyl, ethylcarbonyl, trifluoromethylcarbonyl, methylsulfanyl, methylsulfinyl, methylsulfonyl, trifluoromethylsulfonyl, trifluoromethylsulfanyl and trilfluoromethylsulfinyl;
  • R 6b , R 7b and R 8b are independently selected from H or methyl.
  • Embodiment 17 A compound or salt according to any one of embodiments 1 to 15, wherein
  • R 6a , R 7a and R 8a are independently selected from H, methyl and trifluoromethoxy
  • R 6b , R 7b and R 8b are independently selected from H and methyl.
  • Embodiment 18 A compound or salt according to any one of embodiments 1 to 17, wherein U is -0-.
  • Embodiment 19 A compound or salt according to any one of embodiments 1 to 17, wherein U is selected from -S-, -SO- and -SO2-.
  • Embodiment 20 A compound or salt according to any one of embodiments 1 to 17, wherein U is -S-.
  • Embodiment 21 A compound or salt according to any one of embodiments 1 to 17, wherein U is -SO-.
  • Embodiment 22 A compound or salt according to any one of embodiments 1 to 17, wherein U is -SO2-.
  • Embodiment 22.1 A compound or salt according to any one of embodiments 1 to 17, wherein U is - NR 00 -, and R 00 is selected from H, Ci-Ce-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-Ce-alkoxy, Ci-Ce- alkylcarbonyl, Ci C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci Ce-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 13 substituents independently selected from halogen.
  • Embodiment 22.2 A compound or salt according to any one of embodiments 1 to 17, wherein U is - NR 100 -, and R 00 is selected from H, Ci-Ce-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-Ce-alkoxy, Ci-Ce- alkylcarbonyl, Ci C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci-Ce-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen.
  • Embodiment 23 A compound or salt according to any one of embodiments 1 to 22, wherein
  • Z is selected from C1-C 10-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkoxy-Ci-C 6-alkyl, C2- C io-alkenyl, C2-C 10-alkynyl, -(Co-C 6-alkyl)-C3-C7 heterocycloalkyl, -(Co-C 6-alkyl)-C3-C6-cycloalkyl and Ci-Cio-alkylsulfonyl, wherein each of C1-C 10-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkyl, Ci-C 6-alkoxy-Ci-C 6- alkoxy-Ci-C 6-alkyl, C2-Cio-alkenyl, C2-Cio-alkynyl, -(Co-C 6-alkyl)-C3-C7 heterocycloalkyl, -(Co-C 6-alky
  • Z is selected from Ci-C 6-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkoxy-Ci-C 6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, -(Co-C 6-alkyl)-C3-C7 heterocycloalkyl, -(Co-C 6-alkyl)-C3-C6-cycloalkyl, wherein each of Ci-C 6-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkoxy-Ci-C 6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, -(Co-C 6-alkyl)-C3-C7 heterocycloalkyl, -(Co-C 6-alkyl)-C3-C6-cycloalkyl is unsubstituted or substituted with
  • Embodiment 23.2 A compound or salt according to any one of embodiments 1 to 22, wherein Z is selected from Ci-C 10-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkoxy-Ci-C 6-alkyl, C2- Cio-alkenyl and Ci-Cio-alkylsulfonyl, wherein each of C1-C 10-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkyl, C1-C 6- alkoxy-Ci-C 6-alkoxy-Ci-C 6-alkyl, C2-Cio-alkenyl and Ci-Cio-alkylsulfonyl is unsubstituted or substituted with 1 to 20 substituents independently selected from halogen.
  • Z is selected from Ci-C 10-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkyl, Ci-C 6-alkoxy-Ci-C 6-
  • Embodiment 23.3 A compound or salt according to embodiment 18, wherein
  • Z is selected from C1-C 10-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkoxy-Ci-C 6-alkyl, C2- Cio-alkenyl and Ci-Cio-alkylsulfonyl, wherein each of C1-C 10-alkyl, Ci-C 6-alkoxy-Ci-C 6-alkyl, C1-C 6- alkoxy-Ci-C 6-alkoxy-Ci-C 6-alkyl, C2-Cio-alkenyl and Ci-Cio-alkylsulfonyl is unsubstituted or substituted with 1 to 20 substituents independently selected from halogen.
  • Embodiment 23.4 A compound or salt according to embodiment 18, wherein
  • Z is selected from Ci-Cio-alkyl, which is unsubstituted or substituted with 1 to 20 substituents independently selected from halogen.
  • Embodiment 23.5 A compound or salt according to embodiment 18, wherein
  • Embodiment 23.6 A compound or salt according to embodiment 18, wherein
  • Z is selected from Ci-C 6-alkoxy-Ci-C 6-alkoxy-Ci-C 6-alkyl, which is unsubstituted or substituted with 1 to 20 substituents independently selected from halogen.
  • Embodiment 23.7 A compound or salt according to embodiment 18, wherein
  • Z is selected from C2-Cio-alkenyl, which is unsubstituted or substituted with 1 to 20 substituents independently selected from halogen.
  • Embodiment 23.8 A compound or salt according to embodiment 18, wherein
  • Z is selected from Ci-Cio-alkylsulfonyl, which is unsubstituted or substituted with 1 to 20 substituents independently selected from halogen.
  • Embodiment 23.9 A compound or salt according to any one of embodiments 1 to 17, wherein
  • U-Z is selected from
  • Embodiment 24 A compound or salt according to any one of embodiments 1 to 22, wherein
  • Z is selected from Ci-C 6-alkyl and Ci-C 6-alkoxy-Ci-C 6-alkyl, wherein Ci-C 6-alkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen.
  • Embodiment 25 A compound or salt according to any one of embodiments 1 to 22, wherein
  • Ci-C 6-alkyl is unsubstituted or substituted with 1 to 8 fluoro substituents.
  • Embodiment 26 A compound or salt according to any one of embodiments 1 to 22, wherein
  • Z is selected from -CF 2 H, -CF 3 , -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3
  • Embodiment 27 A compound or salt according to any one of embodiments 1 to 22, wherein
  • Z is selected from methyl, ethyl, 1 ,1-dimethylethyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, bromodichloromethyl, 1 -fluoroethyl, 1-fluoro-1-methylethyl, 2- fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1 ,2,2,2-tetrafluoroethyl, 1-chloro- 1 ,2,2,2- tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2-difluoroethyl, 1 , 1 -difluoroethyl, pentafluoroethyl, heptafluoro-n-propyl, heptafluoro-isopropyl, nonafluoro
  • Z 2 is selected from H, halogen, cyano, nitro, amino, methyl, ethyl, 1 , 1 -dimethylethyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, bromodichloromethyl, 1- fluoroethyl, 1-fluoro-1 methylethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1 ,2,2,2- tetrafluoroethyl, 1 -chloro- 1 ,2,2,2-tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2-difluoroethyl, 1 , 1 - difluoroethyl, pentafluoroethyl heptafluoro-n-propyl, hepta
  • trifluoromethylsulfanyl trifluoromethylsulfinyl, trifluoromethylsulfonyl, chloro-difluoromethylsulfanyl, chloro-difluoromethylsulfinyl, chloro-difluoromethylsulfonyl, dichloro-fluoromethylsulfanyl, dichloro- fluoromethylsulfinyl, dichloro-fluoromethylsulfonyl; and
  • Z 3 is selected from H, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, ethenyl, 1- propenyl, 1-propinyl, 1 -butinyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl,
  • Embodiment 28 A compound or salt according to any one of embodiments 1 to 17, wherein
  • U-Z is selected from
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl, ethyl, phenyl, 4-N02-phenyl and 3-chloro-pyridin-2-yl.
  • Embodiment 28.1 A compound or salt according to any one of embodiments 1 to 22, wherein U is -0-;
  • Z is selected from -CF 2 H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl, ethyl, phenyl, 4-N02-phenyl and 3-chloro-pyridin-2-yl.
  • Embodiment 29 A compound or salt according to any one of embodiments 1 to 4, wherein R is H;
  • Q is selected from 1 -cyano-cyclopropyl, (E)-1 ,2,3,3,3-pentafluoroprop-1-enyl, cyanomethyl, benzyl, cyclopropyl, methyl, ethyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;
  • W is O
  • a 1 is CR 2 or N
  • a 2 is CR 3 or N
  • a 3 is CR 4 or N
  • a 4 is CR 5 or N
  • R 2 and R 5 are independently selected from H, methyl, fluoro and chloro;
  • R 3 and R 4 are independently selected from H, fluoro, chloro, bromo, iodo, cyano, nitro, methyl, ethyl, fluoromethyl, difluoromethyl, chlorodifluoromethyl, trifluoromethyl, 2,2,2-trilfluoroethyl, methoxy, ethoxy, n-propoxy, 1 -methylethoxy, fluoromethoxy, difluoromethoxy, chloro-difluoromethoxy, dichloro- fluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2,2-difluoroethoxy, pentafluoroethoxy, N- methoxyiminomethyl, 1-(N-methoxyimino)-ethyl, methylsulfanyl, trifluoromethylsulfanyl,
  • U-Z is selected from
  • Z 2 is selected from H, halogen, cyano, nitro, amino, methyl, ethyl, 1 , 1 -dimethylethyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, bromodichloromethyl, 1- fluoroethyl, 1-fluoro-1 methylethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1 ,2,2,2- tetrafluoroethyl, 1 -chlor- 1 ,2,2,2-tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2-difluoroethyl, 1 , 1 - difluoroethyl, pentafluoroethyl heptafluoro-n-propyl, heptaflu
  • trifluoromethylsulfanyl trifluoromethylsulfinyl, trifluoromethylsulfonyl, chloro-difluoromethylsulfanyl, chloro-difluoromethylsulfinyl, chloro-difluoromethylsulfonyl, dichloro-fluoromethylsulfanyl, dichloro- fluoromethylsulfinyl, dichloro-fluoromethylsulfonyl; und
  • Z 3 is selected from H, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, ethenyl, 1- propenyl, 1-propinyl, 1 -butinyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl,
  • dichlorofluoromethyl trifluoromethyl, 1 -fluoroethyl, 1 fluoro- 1 -methylethyl, 2-fluoroethyl, 2,2- difluoroethyl, 2,2,2-trifluoroethyl, phenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2,5- dichlorophenyl, 3,4-dichlorophenyl, 2,6-dichlorophenyl 2,6-dichloro-4-trifluoromethylphenyl, 3- chlor-5- trifluoromethylpyridin-2-yl, 4-N02-phenyl and 3-chloro-pyridin-2-yl.
  • Embodiment 29.1 A compound or salt according to any one of embodiments 1 to 4, wherein
  • R is H
  • Q is selected from 1 -cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;
  • W is O;
  • a 1 is CR 2 or N;
  • a 2 is CR 3 or N
  • a 3 is CR 4 or N
  • a 4 is CR 5 or N
  • R 2 and R 5 are independently selected from H, methyl, fluoro and chloro;
  • R 3 and R 4 are independently selected from H, fluoro, chloro, bromo, iodo, cyano, nitro, methyl, ethyl, fluoromethyl, difluoromethyl, chlorodifluoromethyl, trifluoromethyl, 2,2,2-trilfluoroethyl, methoxy, ethoxy, n-propoxy, 1 -methylethoxy, fluoromethoxy, difluoromethoxy, chloro-difluoromethoxy, dichloro- fluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2,2-difluoroethoxy, pentafluoroethoxy, N- methoxyiminomethyl, 1-(N-methoxyimino)-ethyl, methylsulfanyl, trifluoromethylsulfanyl, methylsulfonyl, methylsulfinyl, trifluoromethyls
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci Ge-alkoxy and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci Ge-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from methyl, ethyl, 1 ,1 -dimethylethyl, difluoromethyl, trichloromethyl,
  • Z 2 is selected from H, halogen, cyano, nitro, amino, methyl, ethyl, 1 ,1 -dimethylethyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, bromodichloromethyl, 1- fluoroethyl, 1-fluoro- 1 methylethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1 ,2,2,2- tetrafluoroethyl, 1 -chlor- 1 ,2,2,2-tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2-difluoroethyl, 1 ,1 - difluoroethyl, pentafluoroethyl heptafluoro-n-propyl, hepta
  • trifluoromethylsulfanyl trifluoromethylsulfinyl, trifluoromethylsulfonyl, chloro-difluoromethylsulfanyl, chloro-difluoromethylsulfinyl, chloro-difluoromethylsulfonyl, dichloro-fluoromethylsulfanyl, dichloro- fluoromethylsulfinyl, dichloro-fluoromethylsulfonyl;
  • Z 3 is selected from H, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, ethenyl, 1- propenyl, 1-propinyl, 1 -butinyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl,
  • Embodiment 30 A compound or salt according to any one of embodiments 1 to 4, wherein
  • R is H
  • Q is selected from 1 -cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;
  • W is O
  • a 1 is CR 2 or N
  • a 2 is CR 3 or N
  • a 3 is CR 4 or N
  • a 4 is CR 5 or N
  • R 2 and R 5 are independently selected from H, methyl, fluoro and chloro;
  • R 3 and R 4 are independently selected from H, fluoro, chloro, bromo, iodo, cyano, nitro, methyl, ethyl, fluoromethyl, difluoromethyl, chlorodifluoromethyl, trifluoromethyl, 2,2,2-trilfluoroethyl, methoxy, ethoxy, n-propoxy, 1 -methylethoxy, fluoromethoxy, difluoromethoxy, chloro-difluoromethoxy, dichloro- fluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2,2-difluoroethoxy, pentafluoroethoxy, N- methoxyiminomethyl, 1-(N-methoxyimino)-ethyl, methylsulfanyl, trifluoromethylsulfanyl, methylsulfonyl, methylsulfinyl, trifluoromethyls
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-Ce-alkoxy, Ci-Ce-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is selected from H, halogen, cyano, nitro, amino, methyl, ethyl, 1 ,1 -dimethylethyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, bromodichloromethyl, 1- fluoroethyl, 1-fluoro-1 methylethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1 ,2,2,2- tetrafluoroethyl, 1 -chlor- 1 ,2,2,2-tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2-difluoroethyl, 1 ,1 - difluoroethyl, pentafluoroethyl heptafluoro-n-propyl, heptaflu
  • trifluoromethylsulfanyl trifluoromethylsulfinyl, trifluoromethylsulfonyl, chloro-difluoromethylsulfanyl, chloro-difluoromethylsulfinyl, chloro-difluoromethylsulfonyl, dichloro-fluoromethylsulfanyl, dichloro- fluoromethylsulfinyl, dichloro-fluoromethylsulfonyl;
  • Z 3 is selected from H, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, ethenyl, 1- propenyl, 1-propinyl, 1 -butinyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl,
  • dichlorofluoromethyl trifluoromethyl, 1 -fluoroethyl, 1 fluoro- 1 -methylethyl, 2-fluoroethyl, 2,2- difluoroethyl, 2,2,2-trifluoroethyl, phenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2,5- dichlorophenyl, 3,4-dichlorophenyl, 2,6-dichlorophenyl 2,6-dichloro-4-trifluoromethylphenyl, 3- chlor-5- trifluoromethylpyridin-2-yl, 4-N02-phenyl and 3-chloro-pyridin-2-yl.
  • Embodiment 31 A compound or salt according to any one of embodiments 1 to 4, wherein
  • R 6a , R 7a and R 8a are independently selected from H, methyl and trifluoromethoxy
  • R 6b , R 7b and R 8b are independently selected from H and methyl.
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • Z is selected from -CF 2 H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl, ethyl, phenyl, 4-N02-phenyl and 3-chloropyridin-2-yl.
  • Embodiment 32 A compound or salt according to any one of embodiments 1 to 4, wherein
  • R 6a , R 7a and R 8a are independently selected from H, methyl and trifluoromethoxy
  • R 6b , R 7b and R 8b are independently selected from H and methyl.
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl, ethyl, phenyl, 4-N02-phenyl and 3-chloropyridin-2-yl.
  • Embodiment 33 A compound or salt according to any one of embodiments 1 to 4, wherein
  • R 6a , R 7a and R 8a are independently selected from H, methyl and trifluoromethoxy
  • R 6b , R 7b and R 8b are independently selected from H and methyl.
  • R is H;
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • Z is selected from -CF 2 H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3.
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl, ethyl, phenyl, 4-N02-phenyl and 3-chloropyridin-2-yl.
  • Embodiment 34 A compound or salt according to any one of embodiments 1 to 4, wherein
  • R 6a , R 7a and R 8a are independently selected from H, methyl and trifluoromethoxy
  • R 6b , R 7b and R 8b are independently selected from H and methyl.
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl, ethyl, phenyl, 4-N02-phenyl and 3-chloropyridin-2-yl.
  • Embodiment 34.1 A compound or salt according to any one of embodiments 1 to 4, wherein
  • R 6a , R 7a and R 8a are independently selected from H, methyl and trifluoromethoxy
  • R 6b , R 7b and R 8b are independently selected from H and methyl.
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF;
  • a 3 is CH or CCI;
  • U is -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF 2 H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl, ethyl, phenyl, 4-N02-phenyl and 3-chloropyridin-2-yl.
  • Embodiment 35 A compound or salt according to embodiment 1 , wherein
  • R 6a and R 7a are independently selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 100 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 36 A compound or salt according to embodiment 1 , wherein
  • R 6a and R 8a are independently selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Embodiment 37 A compound or salt according to embodiment 1 , wherein
  • R 8a is selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1 -cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 100 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF 2 H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 38 A compound or salt according to embodiment 1 , wherein
  • R 8a is selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 39 A compound or salt according to embodiment 1 , wherein
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl; W is O;
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci C6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci C6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Embodiment 40 A compound or salt according to embodiment 1 , wherein
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 100 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-Ce-alkoxy, Ci-Ce-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci C6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 41 A compound or salt according to embodiment 1 , wherein
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-Ce-alkoxy, Ci-Ce-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 42 A compound or salt according to embodiment 1 , wherein
  • R 8b is selected from H , methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 100 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-Ce-alkoxy, Ci-Ce-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- Ce-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF 2 H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 44 A compound or salt according to embodiment 1 , wherein
  • R 7b is selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci Ge-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 45 A compound or salt according to embodiment 1 , wherein
  • R 6b is selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl; W is O;
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci C6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci C6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Embodiment 46 A compound or salt according to embodiment 1 , wherein
  • R is H
  • Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 100 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-Ce-alkoxy, Ci-Ce-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci C6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 47 A compound or salt according to embodiment 1 , wherein
  • R 6b and R 7a are independently selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Embodiment 48 A compound or salt according to embodiment 1 , wherein
  • R 7a and R 8b are selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 100 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF 2 H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 49 A compound or salt according to embodiment 1 , wherein
  • R 6a and R 8b are independently selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Embodiment 50 A compound or salt according to embodiment 1 , wherein
  • R 6a and R 7b are independently selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Embodiment 51 A compound or salt according to embodiment 1 , wherein
  • R 6a and R 7a are independently selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1 -cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 100 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF 2 H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 52 A compound or salt according to embodiment 1 , wherein
  • R 6a and R 7a are independently selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Embodiment 53 A compound or salt according to embodiment 1 , wherein
  • R 7a is selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-Ce-alkoxy, Ci-Ce-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 54 A compound or salt according to embodiment 1 , wherein
  • R 6a and R 8a are independently selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 100 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-Ce-alkoxy, Ci-Ce-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- Ce-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF 2 H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 55 A compound or salt according to embodiment 1 , wherein
  • R 6b and R 8a are independently selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 56 A compound or salt according to embodiment 1 , wherein
  • R 7b and R 8a are independently selected from H, methyl and trifluoromethoxy
  • R is H;
  • Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 57 A compound or salt according to embodiment 1 , wherein
  • R 8a is selected from H , methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 100 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Embodiment 58 A compound or salt according to embodiment 1 , wherein
  • R 8a is selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 59 A compound or salt according to embodiment 1 , wherein
  • R 7a is selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 100 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF 2 H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 60 A compound or salt according to embodiment 1 , wherein
  • R 6a is selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Embodiment 61 A compound or salt according to embodiment 1 , wherein
  • R 6a is selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-Ce-alkoxy, Ci-Ce-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 62 A compound or salt according to embodiment 1 , wherein
  • R 7a is selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 100 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-Ce-alkoxy, Ci-Ce-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- Ce-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF 2 H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 63 A compound or salt according to embodiment 1 , wherein
  • R 7a is selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 64 A compound or salt according to embodiment 1 , wherein
  • R 6a is selected from H , methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl; W is O;
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci C6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci C6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Embodiment 65 A compound or salt according to embodiment 1 , wherein
  • R 7a is selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 100 -;
  • R 00 is selected from H, Ci C6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci C6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Embodiment 66 A compound or salt according to embodiment 1 , wherein
  • R 6a is selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 67 A compound or salt according to embodiment 1 , wherein
  • R 7a and R 8a are independently selected from H, methyl and trifluoromethoxy
  • R is H
  • Q is selected from 1 -cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 100 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF 2 H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 68 A compound or salt according to embodiment 1 , wherein
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-Ce-alkoxy, Ci-Ce-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 69 A compound or salt according to embodiment 1 , wherein
  • R is H
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O; A 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 70 A compound or salt according to embodiment 1 , wherein
  • R is H
  • R 6a , R 7a and R 8a are independently selected from H, methyl and trifluoromethoxy
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 100 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-Ce-alkoxy, Ci-Ce-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 71 A compound or salt according to embodiment 1 , wherein
  • R is H
  • R 6a and R 8a are independently selected from H, methyl and trifluoromethoxy
  • Q is selected from 1 -cyano-cyclopropyl, (E)-1 ,2,3,3,3-pentafluoroprop-1-enyl, cyanomethyl, benzyl, cyclopropyl, methyl, ethyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U-Z is selected from
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 72 A compound or salt according to embodiment 1 , wherein
  • R is H
  • R 7a and R 8a are independently selected from H, methyl and trifluoromethoxy
  • Q is selected from 1 -cyano-cyclopropyl, (E)-1 ,2,3,3,3-pentafluoroprop-1-enyl, cyanomethyl, benzyl, cyclopropyl, methyl, ethyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl; W is O;
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U-Z 1 is selected from
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 72.1 A compound or salt according to embodiment 1 , wherein
  • R is H
  • R 7a and R 8a are independently selected from H, methyl and trifluoromethoxy
  • Q is selected from 1 -cyano-cyclopropyl, (E)-1 ,2,3,3,3-pentafluoroprop-1-enyl, cyanomethyl, benzyl, cyclopropyl, methyl, ethyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H , Ci-Ce-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci-Ce-alkoxy, Ci-Ce-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci C6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF 2 H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 72.2 A compound or salt according to embodiment 1 , wherein
  • R is H
  • R 7a and R 8a are independently selected from H, methyl and trifluoromethoxy
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci-Ce-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Z 3 is selected from methyl and ethyl.
  • Embodiment 7 A compound or salt according to embodiment 1 , wherein
  • R is H
  • R 6a and R 7a are independently selected from H, methyl and trifluoromethoxy
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl; W is O;
  • a 1 and A4 are CH;
  • a 2 is CH or CF
  • a 3 is CH or CCI
  • U is selected from -0-, -S-, -SO-, -SO2- and -NR 00 -;
  • R 00 is selected from H, Ci C6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci C6-alkoxy, Ci C6-alkylcarbonyl, Ci- C6-alkoxycarbonyl and C3-C6-cycloalkyl, wherein each of Ci C6-alkyl, C2-C 6-alkenyl, C2-C 6-alkynyl, Ci- C6-alkoxy and C3-C6-cycloalkyl is unsubstituted or substituted with 1 to 8 substituents independently selected from halogen;
  • Z is selected from -CF2H, -CF2CFHCF3, -CF2CF2CF3, -CF2CF2H, -CF2CF2OCF3, -CH2CF2CF3, - CH(CF 3 )CH 2 CF3 and -CH2CF3;
  • Z 2 is CF 3 ;
  • Embodiment 74 A compound or salt according to embodiment 1 , wherein
  • R is H
  • R 6a is selected from H , methyl and trifluoromethoxy
  • Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl, carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1-carbamoylcyclopropyl;
  • W is O
  • a 1 and A4 are CH;
  • a 2 is CH or CF

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PCT/EP2016/081167 2015-12-22 2016-12-15 Pesticidally active pyrazole derivatives Ceased WO2017108569A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CN201680075075.3A CN108463109B (zh) 2015-12-22 2016-12-15 杀有害生物活性吡唑衍生物
JP2018532553A JP6943857B2 (ja) 2015-12-22 2016-12-15 有害生物防除活性ピラゾール誘導体
BR112018012926-7A BR112018012926B1 (pt) 2015-12-22 2016-12-15 Derivados de pirazol ativos em termos pesticidas, composição pesticida, método para controle de pragas, método para a proteção de material de propagação vegetal do ataque por pragas e material de propagação vegetal revestido
EP16809111.4A EP3393245A1 (en) 2015-12-22 2016-12-15 Pesticidally active pyrazole derivatives
MX2018007527A MX2018007527A (es) 2015-12-22 2016-12-15 Derivados de pirazol activos como pesticidas.
US16/064,916 US10750742B2 (en) 2015-12-22 2016-12-15 Pesticidally active pyrazole derivatives
CA3006911A CA3006911C (en) 2015-12-22 2016-12-15 PYRAZOLE DERIVATIVES WITH PESTICIDAL ACTIVITY
CONC2018/0006320A CO2018006320A2 (es) 2015-12-22 2018-06-19 Derivados de pirazol activos como pesticida

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP15202160 2015-12-22
EP15202160.6 2015-12-22
EP16169454.2 2016-05-12
EP16169454 2016-05-12

Publications (1)

Publication Number Publication Date
WO2017108569A1 true WO2017108569A1 (en) 2017-06-29

Family

ID=57530716

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2016/081167 Ceased WO2017108569A1 (en) 2015-12-22 2016-12-15 Pesticidally active pyrazole derivatives

Country Status (11)

Country Link
US (1) US10750742B2 (enExample)
EP (1) EP3393245A1 (enExample)
JP (1) JP6943857B2 (enExample)
CN (1) CN108463109B (enExample)
BR (1) BR112018012926B1 (enExample)
CA (1) CA3006911C (enExample)
CL (1) CL2018001710A1 (enExample)
CO (1) CO2018006320A2 (enExample)
EC (1) ECSP18047467A (enExample)
MX (1) MX2018007527A (enExample)
WO (1) WO2017108569A1 (enExample)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018234240A1 (en) 2017-06-19 2018-12-27 Syngenta Participations Ag PYRAZOLE DERIVATIVES WITH PESTICIDE ACTIVITY
WO2019068819A1 (en) 2017-10-06 2019-04-11 Syngenta Participations Ag PYRROLE DERIVATIVES ACTIVE ON THE PESTICIDE PLAN
US10618916B2 (en) 2018-05-11 2020-04-14 Incyte Corporation Heterocyclic compounds as immunomodulators
US10669271B2 (en) 2018-03-30 2020-06-02 Incyte Corporation Heterocyclic compounds as immunomodulators
WO2020127345A1 (en) 2018-12-21 2020-06-25 Syngenta Participations Ag Pesticidally active pyrazole derivatives
US10793565B2 (en) 2016-12-22 2020-10-06 Incyte Corporation Heterocyclic compounds as immunomodulators
US10800768B2 (en) 2016-12-22 2020-10-13 Incyte Corporation Heterocyclic compounds as immunomodulators
US10806785B2 (en) 2016-12-22 2020-10-20 Incyte Corporation Immunomodulator compounds and methods of use
US11401279B2 (en) 2019-09-30 2022-08-02 Incyte Corporation Pyrido[3,2-d]pyrimidine compounds as immunomodulators
US11407749B2 (en) 2015-10-19 2022-08-09 Incyte Corporation Heterocyclic compounds as immunomodulators
US11465981B2 (en) 2016-12-22 2022-10-11 Incyte Corporation Heterocyclic compounds as immunomodulators
US11535615B2 (en) 2015-12-22 2022-12-27 Incyte Corporation Heterocyclic compounds as immunomodulators
US11572366B2 (en) 2015-11-19 2023-02-07 Incyte Corporation Heterocyclic compounds as immunomodulators
US11608337B2 (en) 2016-05-06 2023-03-21 Incyte Corporation Heterocyclic compounds as immunomodulators
US11613536B2 (en) 2016-08-29 2023-03-28 Incyte Corporation Heterocyclic compounds as immunomodulators
US11673883B2 (en) 2016-05-26 2023-06-13 Incyte Corporation Heterocyclic compounds as immunomodulators
US11718605B2 (en) 2016-07-14 2023-08-08 Incyte Corporation Heterocyclic compounds as immunomodulators
US11753406B2 (en) 2019-08-09 2023-09-12 Incyte Corporation Salts of a PD-1/PD-L1 inhibitor
US11760756B2 (en) 2020-11-06 2023-09-19 Incyte Corporation Crystalline form of a PD-1/PD-L1 inhibitor
US11780836B2 (en) 2020-11-06 2023-10-10 Incyte Corporation Process of preparing a PD-1/PD-L1 inhibitor
US11866434B2 (en) 2020-11-06 2024-01-09 Incyte Corporation Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof
US11866451B2 (en) 2019-11-11 2024-01-09 Incyte Corporation Salts and crystalline forms of a PD-1/PD-L1 inhibitor
US11873309B2 (en) 2016-06-20 2024-01-16 Incyte Corporation Heterocyclic compounds as immunomodulators
US12466822B2 (en) 2016-12-22 2025-11-11 Incyte Corporation Heterocyclic compounds as immunomodulators

Citations (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0353191A2 (en) 1988-07-29 1990-01-31 Ciba-Geigy Ag DNA sequences encoding polypeptides having beta-1,3-glucanase activity
EP0367474A1 (en) 1988-11-01 1990-05-09 Mycogen Corporation Novel bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
EP0374753A2 (de) 1988-12-19 1990-06-27 American Cyanamid Company Insektizide Toxine, Gene, die diese Toxine kodieren, Antikörper, die sie binden, sowie transgene Pflanzenzellen und transgene Pflanzen, die diese Toxine exprimieren
EP0392225A2 (en) 1989-03-24 1990-10-17 Ciba-Geigy Ag Disease-resistant transgenic plants
WO1990013651A1 (en) 1989-05-09 1990-11-15 Imperial Chemical Industries Plc Bacterial genes
EP0401979A2 (en) 1989-05-18 1990-12-12 Mycogen Corporation Novel bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
EP0427529A1 (en) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
EP0451878A1 (en) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modifying plants by genetic engineering to combat or control insects
WO1993007278A1 (en) 1991-10-04 1993-04-15 Ciba-Geigy Ag Synthetic dna sequence having enhanced insecticidal activity in maize
WO1995033818A2 (en) 1994-06-08 1995-12-14 Ciba-Geigy Ag Genes for the synthesis of antipathogenic substances
WO1995034656A1 (en) 1994-06-10 1995-12-21 Ciba-Geigy Ag Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
US5631072A (en) 1995-03-10 1997-05-20 Avondale Incorporated Method and means for increasing efficacy and wash durability of insecticide treated fabric
WO2000015615A1 (en) 1998-09-15 2000-03-23 Syngenta Participations Ag Pyridine ketones useful as herbicides
WO2002015701A2 (en) 2000-08-25 2002-02-28 Syngenta Participations Ag Bacillus thuringiensis crystal protein hybrids
EP1253128A1 (en) 2000-02-04 2002-10-30 Nihon Nohyaku Co., Ltd. Perfluoroisopropylbenzene derivatives
WO2003000906A2 (en) 2001-06-22 2003-01-03 Syngenta Participations Ag Plant disease resistance genes
WO2003018810A2 (en) 2001-08-31 2003-03-06 Syngenta Participations Ag Modified cry3a toxins and nucleic acid sequences coding therefor
WO2003034823A1 (en) 2001-10-25 2003-05-01 Siamdutch Mosquito Netting Company Limited Treatment of fabric materials with an insecticide
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
WO2004099146A1 (en) 2003-05-12 2004-11-18 Pfizer Products Inc. Benzamide inhibitors of the p2x7 receptor
WO2005064072A2 (en) 2003-12-22 2005-07-14 Basf Aktiengesellschaft Composition for the impregnation of fibers, fabrics and nettings imparting a protective activity against pests
WO2005113886A1 (de) 2004-05-12 2005-12-01 Basf Aktiengesellschaft Verfahren zur behandlung von flexiblen substraten
WO2006044505A2 (en) 2004-10-13 2006-04-27 Ptc Therapeutics, Inc. Compounds for nonsense suppression, and methods for their use
WO2006087343A1 (de) 2005-02-16 2006-08-24 Basf Aktiengesellschaft Pyrazolcarbonsäureanilide, verfahren zu ihrer herstellung und sie enthaltende mittel zur bekämpfung von schadpilzen
EP1724392A2 (de) 2005-05-04 2006-11-22 Fritz Blanke Gmbh & Co. Kg Verfahren zur antimikrobiellen Ausrüstung von textilen Flächengebilden
WO2006128870A2 (en) 2005-06-03 2006-12-07 Basf Aktiengesellschaft Composition for the impregnation of fibers, fabrics and nettings imparting a protective activity against pests
WO2007048556A1 (en) 2005-10-25 2007-05-03 Syngenta Participations Ag Heterocyclic amide derivatives useful as microbiocides
WO2007090739A1 (de) 2006-02-03 2007-08-16 Basf Se Verfahren zum behandeln von substraten
WO2008080969A1 (en) 2006-12-29 2008-07-10 Abbott Gmbh & Co. Kg Carboxamide compounds and their use as calpain inhibitors
WO2008148868A1 (en) 2007-06-08 2008-12-11 Janssen Pharmaceutica N.V. Piperidine/piperazine derivatives
WO2008151984A1 (en) 2007-06-12 2008-12-18 Basf Se Aqueous formulation and process for the impregnation of non-living-materials imparting a protective activity against pests
WO2009051245A1 (ja) 2007-10-18 2009-04-23 Kumiai Chemical Industry Co., Ltd. ３－アルコキシ－１－フェニルピラゾ－ル誘導体及び有害生物防除剤
WO2009149837A1 (en) 2008-06-09 2009-12-17 Bayer Schering Pharma Aktiengesellschaft Substituted 4- (indazolyl) -1,4-dihydropyridines and methods of use thereof
WO2010051926A2 (de) 2008-11-05 2010-05-14 Bayer Cropscience Aktiengesellschaft Halogen-substituierte verbindungen als pestizide
WO2010078905A1 (de) 2009-01-07 2010-07-15 Merck Patent Gmbh Benzothiazolonderivate
WO2010078910A1 (de) 2009-01-07 2010-07-15 Merck Patent Gmbh Pyridazinonderivate
WO2010133312A1 (de) 2009-05-20 2010-11-25 Bayer Cropscience Aktiengesellschaft Halogen-substituierte verbindungen als pestizide
US20110053904A1 (en) 2009-08-27 2011-03-03 Sabine Kolczewski Carbocyclic glyt1 receptor antagonists
WO2011088181A1 (en) 2010-01-13 2011-07-21 Tempero Pharmaceuticals, Inc. Compounds and methods
WO2012004604A1 (en) 2010-07-09 2012-01-12 Convergence Pharmaceuticals Limited Tetrazole compounds as calcium channel blockers
WO2012069366A1 (en) 2010-11-23 2012-05-31 Syngenta Participations Ag Insecticidal compounds
WO2012092115A1 (en) 2010-12-29 2012-07-05 E. I. Du Pont De Nemours And Company Mesoionic pyrido [1,2 -a] pyrimidine pesticides
WO2012107434A1 (en) 2011-02-09 2012-08-16 Syngenta Participations Ag Insecticidal compounds
WO2012158413A2 (en) 2011-05-13 2012-11-22 Array Biopharma Inc. Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
WO2012166951A1 (en) 2011-05-31 2012-12-06 Receptos, Inc. Novel glp-1 receptor stabilizers and modulators
WO2012175474A1 (en) 2011-06-20 2012-12-27 Syngenta Participations Ag 1,2,3 triazole pesticides
WO2013009791A1 (en) 2011-07-12 2013-01-17 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
WO2014122083A1 (de) 2013-02-06 2014-08-14 Bayer Cropscience Ag Halogensubstituierte pyrazolderivate als schädlingsbekämpfungsmittel
WO2015067647A1 (de) 2013-11-05 2015-05-14 Bayer Cropscience Ag Substituierte benzamide zur behandlung von arthropoden
WO2015067648A1 (de) 2013-11-05 2015-05-14 Bayer Cropscience Ag Neue verbindungen zur bekämpfung von arthropoden
WO2015150442A1 (de) 2014-04-02 2015-10-08 Bayer Cropscience Ag Neue 3-[(pyrazol-5-yl)-heteroaryl]-benzamid derivate und ihre verwendung als schädlingsbekämpfungsmittel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5743418B2 (ja) * 2010-04-09 2015-07-01 Ｏａｔアグリオ株式会社 新規なピラゾール化合物、その製造方法及び有害生物防除剤
JP2014510049A (ja) * 2011-02-09 2014-04-24 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 殺虫性化合物
JP2013256468A (ja) * 2012-06-13 2013-12-26 Nissan Chem Ind Ltd 動物の寄生虫防除剤

Patent Citations (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0451878A1 (en) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modifying plants by genetic engineering to combat or control insects
EP0353191A2 (en) 1988-07-29 1990-01-31 Ciba-Geigy Ag DNA sequences encoding polypeptides having beta-1,3-glucanase activity
EP0367474A1 (en) 1988-11-01 1990-05-09 Mycogen Corporation Novel bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
EP0374753A2 (de) 1988-12-19 1990-06-27 American Cyanamid Company Insektizide Toxine, Gene, die diese Toxine kodieren, Antikörper, die sie binden, sowie transgene Pflanzenzellen und transgene Pflanzen, die diese Toxine exprimieren
EP0392225A2 (en) 1989-03-24 1990-10-17 Ciba-Geigy Ag Disease-resistant transgenic plants
WO1990013651A1 (en) 1989-05-09 1990-11-15 Imperial Chemical Industries Plc Bacterial genes
EP0401979A2 (en) 1989-05-18 1990-12-12 Mycogen Corporation Novel bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
EP0427529A1 (en) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
WO1993007278A1 (en) 1991-10-04 1993-04-15 Ciba-Geigy Ag Synthetic dna sequence having enhanced insecticidal activity in maize
WO1995033818A2 (en) 1994-06-08 1995-12-14 Ciba-Geigy Ag Genes for the synthesis of antipathogenic substances
WO1995034656A1 (en) 1994-06-10 1995-12-21 Ciba-Geigy Ag Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
US5631072A (en) 1995-03-10 1997-05-20 Avondale Incorporated Method and means for increasing efficacy and wash durability of insecticide treated fabric
WO2000015615A1 (en) 1998-09-15 2000-03-23 Syngenta Participations Ag Pyridine ketones useful as herbicides
EP1253128A1 (en) 2000-02-04 2002-10-30 Nihon Nohyaku Co., Ltd. Perfluoroisopropylbenzene derivatives
WO2002015701A2 (en) 2000-08-25 2002-02-28 Syngenta Participations Ag Bacillus thuringiensis crystal protein hybrids
WO2003000906A2 (en) 2001-06-22 2003-01-03 Syngenta Participations Ag Plant disease resistance genes
WO2003018810A2 (en) 2001-08-31 2003-03-06 Syngenta Participations Ag Modified cry3a toxins and nucleic acid sequences coding therefor
WO2003034823A1 (en) 2001-10-25 2003-05-01 Siamdutch Mosquito Netting Company Limited Treatment of fabric materials with an insecticide
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
WO2004099146A1 (en) 2003-05-12 2004-11-18 Pfizer Products Inc. Benzamide inhibitors of the p2x7 receptor
WO2005064072A2 (en) 2003-12-22 2005-07-14 Basf Aktiengesellschaft Composition for the impregnation of fibers, fabrics and nettings imparting a protective activity against pests
WO2005113886A1 (de) 2004-05-12 2005-12-01 Basf Aktiengesellschaft Verfahren zur behandlung von flexiblen substraten
WO2006044505A2 (en) 2004-10-13 2006-04-27 Ptc Therapeutics, Inc. Compounds for nonsense suppression, and methods for their use
WO2006087343A1 (de) 2005-02-16 2006-08-24 Basf Aktiengesellschaft Pyrazolcarbonsäureanilide, verfahren zu ihrer herstellung und sie enthaltende mittel zur bekämpfung von schadpilzen
EP1724392A2 (de) 2005-05-04 2006-11-22 Fritz Blanke Gmbh & Co. Kg Verfahren zur antimikrobiellen Ausrüstung von textilen Flächengebilden
WO2006128870A2 (en) 2005-06-03 2006-12-07 Basf Aktiengesellschaft Composition for the impregnation of fibers, fabrics and nettings imparting a protective activity against pests
WO2007048556A1 (en) 2005-10-25 2007-05-03 Syngenta Participations Ag Heterocyclic amide derivatives useful as microbiocides
WO2007090739A1 (de) 2006-02-03 2007-08-16 Basf Se Verfahren zum behandeln von substraten
WO2008080969A1 (en) 2006-12-29 2008-07-10 Abbott Gmbh & Co. Kg Carboxamide compounds and their use as calpain inhibitors
WO2008148868A1 (en) 2007-06-08 2008-12-11 Janssen Pharmaceutica N.V. Piperidine/piperazine derivatives
WO2008151984A1 (en) 2007-06-12 2008-12-18 Basf Se Aqueous formulation and process for the impregnation of non-living-materials imparting a protective activity against pests
WO2009051245A1 (ja) 2007-10-18 2009-04-23 Kumiai Chemical Industry Co., Ltd. ３－アルコキシ－１－フェニルピラゾ－ル誘導体及び有害生物防除剤
WO2009149837A1 (en) 2008-06-09 2009-12-17 Bayer Schering Pharma Aktiengesellschaft Substituted 4- (indazolyl) -1,4-dihydropyridines and methods of use thereof
WO2010051926A2 (de) 2008-11-05 2010-05-14 Bayer Cropscience Aktiengesellschaft Halogen-substituierte verbindungen als pestizide
WO2010078905A1 (de) 2009-01-07 2010-07-15 Merck Patent Gmbh Benzothiazolonderivate
WO2010078910A1 (de) 2009-01-07 2010-07-15 Merck Patent Gmbh Pyridazinonderivate
WO2010133312A1 (de) 2009-05-20 2010-11-25 Bayer Cropscience Aktiengesellschaft Halogen-substituierte verbindungen als pestizide
US20110053904A1 (en) 2009-08-27 2011-03-03 Sabine Kolczewski Carbocyclic glyt1 receptor antagonists
WO2011088181A1 (en) 2010-01-13 2011-07-21 Tempero Pharmaceuticals, Inc. Compounds and methods
WO2012004604A1 (en) 2010-07-09 2012-01-12 Convergence Pharmaceuticals Limited Tetrazole compounds as calcium channel blockers
WO2012069366A1 (en) 2010-11-23 2012-05-31 Syngenta Participations Ag Insecticidal compounds
WO2012092115A1 (en) 2010-12-29 2012-07-05 E. I. Du Pont De Nemours And Company Mesoionic pyrido [1,2 -a] pyrimidine pesticides
WO2012107434A1 (en) 2011-02-09 2012-08-16 Syngenta Participations Ag Insecticidal compounds
WO2012158413A2 (en) 2011-05-13 2012-11-22 Array Biopharma Inc. Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
WO2012166951A1 (en) 2011-05-31 2012-12-06 Receptos, Inc. Novel glp-1 receptor stabilizers and modulators
WO2012175474A1 (en) 2011-06-20 2012-12-27 Syngenta Participations Ag 1,2,3 triazole pesticides
WO2013009791A1 (en) 2011-07-12 2013-01-17 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
WO2014122083A1 (de) 2013-02-06 2014-08-14 Bayer Cropscience Ag Halogensubstituierte pyrazolderivate als schädlingsbekämpfungsmittel
WO2015067647A1 (de) 2013-11-05 2015-05-14 Bayer Cropscience Ag Substituierte benzamide zur behandlung von arthropoden
WO2015067646A1 (de) 2013-11-05 2015-05-14 Bayer Cropscience Ag Substituierte benzamide zur behandlung von arthropoden
WO2015067648A1 (de) 2013-11-05 2015-05-14 Bayer Cropscience Ag Neue verbindungen zur bekämpfung von arthropoden
WO2015150442A1 (de) 2014-04-02 2015-10-08 Bayer Cropscience Ag Neue 3-[(pyrazol-5-yl)-heteroaryl]-benzamid derivate und ihre verwendung als schädlingsbekämpfungsmittel

Non-Patent Citations (17)

* Cited by examiner, † Cited by third party
Title
"The Pesticide Manual - A World Compendium", THE BRITISH CROP PROTECTION COUNCIL
A. KAHEHI; S. ITO; H. ISAWA; T. TAKASHIMA, CHEM. PHARM. BULL., vol. 38, no. 10, 1990, pages 266
A. WOOD: "Compendium of Pesticide Common Names", 1995
CHINCHILLA, RAFAEL ET AL., CHEMICAL REVIEWS, vol. 107, no. 3, 2007, pages 874 - 922
D. MA ET AL., J. ORG. CHEM., vol. 74, 2009, pages 4542
D. MA ET AL., ORG. LETT., vol. 17, 2015, pages 5934
H. METZGER: "Houben-Weyl", vol. X/4, 1968, GEORG THIEME VERLAG, pages: 55 FF
H. MIMURA ET AL., J. FLUOR. CHEM., vol. 131, 2010, pages 477
I. KIELTSCH; P. EISENBERGER; A. TOGNI, ANGEW. CHEM. INT. ED., vol. 46, 2007, pages 754
J. HARTWIG ET AL., J. AM. CHEM. SOC., vol. 131, 2009, pages 11049
J. HARTWIG ET AL., J. AM. CHEM. SOC., vol. 137, 2015, pages 8460
J. MED. CHEM., vol. 32, no. 12, 1989, pages 2561 - 2573
M. TAILLEFER ET AL., ANGEW. CHEM. INT. ED., vol. 48, 2009, pages 337
P.G.M. WUTS; T.W. GREENE: "Greene's protective groups in organic synthesis", 2007, JOHN WILEY & SONS, INC., pages: 927 - 933
PROC. BCPC, INT. CONGR., vol. 1, 2003, pages 93
QUIAN LI ET AL., ORG. LETT., vol. 16, 2014, pages 1622
RAFAEL ET AL., CHEMICAL REVIEWS, vol. 40, no. 10, 2007, pages 5084 - 5121

Cited By (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11407749B2 (en) 2015-10-19 2022-08-09 Incyte Corporation Heterocyclic compounds as immunomodulators
US11572366B2 (en) 2015-11-19 2023-02-07 Incyte Corporation Heterocyclic compounds as immunomodulators
US11535615B2 (en) 2015-12-22 2022-12-27 Incyte Corporation Heterocyclic compounds as immunomodulators
US11866435B2 (en) 2015-12-22 2024-01-09 Incyte Corporation Heterocyclic compounds as immunomodulators
US11608337B2 (en) 2016-05-06 2023-03-21 Incyte Corporation Heterocyclic compounds as immunomodulators
US11673883B2 (en) 2016-05-26 2023-06-13 Incyte Corporation Heterocyclic compounds as immunomodulators
US11873309B2 (en) 2016-06-20 2024-01-16 Incyte Corporation Heterocyclic compounds as immunomodulators
US11718605B2 (en) 2016-07-14 2023-08-08 Incyte Corporation Heterocyclic compounds as immunomodulators
US11613536B2 (en) 2016-08-29 2023-03-28 Incyte Corporation Heterocyclic compounds as immunomodulators
US11465981B2 (en) 2016-12-22 2022-10-11 Incyte Corporation Heterocyclic compounds as immunomodulators
US10800768B2 (en) 2016-12-22 2020-10-13 Incyte Corporation Heterocyclic compounds as immunomodulators
US10806785B2 (en) 2016-12-22 2020-10-20 Incyte Corporation Immunomodulator compounds and methods of use
US10793565B2 (en) 2016-12-22 2020-10-06 Incyte Corporation Heterocyclic compounds as immunomodulators
US11339149B2 (en) 2016-12-22 2022-05-24 Incyte Corporation Heterocyclic compounds as immunomodulators
US11787793B2 (en) 2016-12-22 2023-10-17 Incyte Corporation Heterocyclic compounds as immunomodulators
US12466822B2 (en) 2016-12-22 2025-11-11 Incyte Corporation Heterocyclic compounds as immunomodulators
US11566026B2 (en) 2016-12-22 2023-01-31 Incyte Corporation Heterocyclic compounds as immunomodulators
US11589585B2 (en) 2017-06-19 2023-02-28 Syngenta Participations Ag Pesticidally active pyrazole derivatives
JP7202371B2 (ja) 2017-06-19 2023-01-11 シンジェンタ パーティシペーションズ アーゲー 殺有害生物的に活性なピラゾール誘導体
JP2020524183A (ja) * 2017-06-19 2020-08-13 シンジェンタ パーティシペーションズ アーゲー 殺有害生物的に活性なピラゾール誘導体
CN110770223A (zh) * 2017-06-19 2020-02-07 先正达参股股份有限公司 杀有害生物活性吡唑衍生物
US11071300B2 (en) 2017-06-19 2021-07-27 Syngenta Participations Ag Pesticidally active pyrazole derivatives
WO2018234240A1 (en) 2017-06-19 2018-12-27 Syngenta Participations Ag PYRAZOLE DERIVATIVES WITH PESTICIDE ACTIVITY
CN110770223B (zh) * 2017-06-19 2023-08-22 先正达参股股份有限公司 杀有害生物活性吡唑衍生物
WO2019068819A1 (en) 2017-10-06 2019-04-11 Syngenta Participations Ag PYRROLE DERIVATIVES ACTIVE ON THE PESTICIDE PLAN
US10669271B2 (en) 2018-03-30 2020-06-02 Incyte Corporation Heterocyclic compounds as immunomodulators
US12247026B2 (en) 2018-03-30 2025-03-11 Incyte Corporation Heterocyclic compounds as immunomodulators
US11124511B2 (en) 2018-03-30 2021-09-21 Incyte Corporation Heterocyclic compounds as immunomodulators
US10906920B2 (en) 2018-05-11 2021-02-02 Incyte Corporation Heterocyclic compounds as immunomodulators
US12187743B2 (en) 2018-05-11 2025-01-07 Incyte Corporation Heterocyclic compounds as immunomodulators
US10618916B2 (en) 2018-05-11 2020-04-14 Incyte Corporation Heterocyclic compounds as immunomodulators
US11414433B2 (en) 2018-05-11 2022-08-16 Incyte Corporation Heterocyclic compounds as immunomodulators
WO2020127345A1 (en) 2018-12-21 2020-06-25 Syngenta Participations Ag Pesticidally active pyrazole derivatives
US11753406B2 (en) 2019-08-09 2023-09-12 Incyte Corporation Salts of a PD-1/PD-L1 inhibitor
US12247038B2 (en) 2019-09-30 2025-03-11 Incyte Corporation Pyrido[3,2-d]pyrimidine compounds as immunomodulators
US11401279B2 (en) 2019-09-30 2022-08-02 Incyte Corporation Pyrido[3,2-d]pyrimidine compounds as immunomodulators
US11866451B2 (en) 2019-11-11 2024-01-09 Incyte Corporation Salts and crystalline forms of a PD-1/PD-L1 inhibitor
US12084443B2 (en) 2020-11-06 2024-09-10 Incyte Corporation Process of preparing a PD-1/PD-L1 inhibitor
US11760756B2 (en) 2020-11-06 2023-09-19 Incyte Corporation Crystalline form of a PD-1/PD-L1 inhibitor
US11866434B2 (en) 2020-11-06 2024-01-09 Incyte Corporation Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof
US12404272B2 (en) 2020-11-06 2025-09-02 Incyte Corporation Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof
US11780836B2 (en) 2020-11-06 2023-10-10 Incyte Corporation Process of preparing a PD-1/PD-L1 inhibitor

Also Published As

Publication number Publication date
BR112018012926A2 (en) 2018-12-11
MX2018007527A (es) 2018-09-07
JP2019501171A (ja) 2019-01-17
JP6943857B2 (ja) 2021-10-06
CN108463109A (zh) 2018-08-28
CA3006911C (en) 2024-09-10
CO2018006320A2 (es) 2018-07-10
EP3393245A1 (en) 2018-10-31
CL2018001710A1 (es) 2018-08-03
BR112018012926B1 (pt) 2022-08-16
US20190014783A1 (en) 2019-01-17
US10750742B2 (en) 2020-08-25
ECSP18047467A (es) 2018-06-30
CA3006911A1 (en) 2017-06-29
CN108463109B (zh) 2022-04-29

Similar Documents

Publication Publication Date Title
US10750742B2 (en) Pesticidally active pyrazole derivatives
EP3356352B1 (en) Pesticidally active pyrazole derivatives
EP3416959B1 (en) Pesticidally active pyrazole derivatives
WO2017012970A2 (en) Pesticidally active pyrazole derivatives
EP3664611A1 (en) Pesticidally active pyrazole derivatives
EP3692031B1 (en) Pesticidally active pyrrole derivatives
EP3642194B1 (en) Pesticidally active pyrazole derivatives
EP3665170A1 (en) Pesticidally active thiophene derivatives
US11142519B2 (en) Pesticidally active pyrazole derivatives
US11384074B2 (en) Pesticidally active pyrrole derivatives
EP3665167B1 (en) Pesticidally active pyrazole derivatives
US11472797B2 (en) Pesticidally active pyrazole derivatives
US11040962B2 (en) Pesticidally active pyrazole derivatives
WO2020127345A1 (en) Pesticidally active pyrazole derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16809111

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 3006911

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: MX/A/2018/007527

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 2018532553

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112018012926

Country of ref document: BR

WWE Wipo information: entry into national phase

Ref document number: 2016809111

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2016809111

Country of ref document: EP

Effective date: 20180723

ENP Entry into the national phase

Ref document number: 112018012926

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20180622

WWW Wipo information: withdrawn in national office

Ref document number: 2016809111

Country of ref document: EP